Incorporation of Finasteride-Loaded Microspheres into Personalized Microneedle for Sustained Transdermal Delivery
Langmuir · 21.05.2024 · 40 (20) · 10551-10560
DOI: 10.1021/acs.langmuir.4c00280 ↗Kurz gefasst
Fachartikel in der Zeitschrift Langmuir, online erschienen am 06.05.2024. Verfasst von Wenzuo Luo und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry, Chemical Engineering and Life Sciences, Wuhan University of Technology, Wuhan 430070, P. R. China. Hauptthemen laut MEDLINE: Microspheres, Finasteride, Needles, Administration, Cutaneous. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Wuhan Science and Technology Project, Sanya Yazhou Bay Science and Technology City, Wuhan University of Technology.
Abstract (Originalsprache)
Although finasteride (FNS) tablets are considered the most effective drug for the treatment of androgenetic alopecia (AGA), their clinical applications are limited due to the associated side effects including decreased libido, breast enlargement, and liver dysfunction. In this study, we have developed a personalized microneedle (PMN) with a double-layer structure that incorporates FNS-loaded microspheres (MPs) to accommodate irregular skin surfaces. This design enables the sustained release of FNS, thereby reducing potential side effects. The needle body was synthesized with high-strength hyaluronic acid (HA) as the base material substrate. The backing layer utilized methacrylate gelatin (GelMA) with specific toughness, enabling PMN to penetrate the skin while adapting to various skin environments. The length of PMN needles (10 × 10) was approximately 600 μm, with the bottom of the needles measuring about 330 μm × 330 μm. The distance between adjacent tips was around 600 μm, allowing the drug to penetrate the stratum corneum of the skin. The results of the drug release investigation indicated the sustained and regulated release of FNS from PMN, as compared to that of pure FNS and FNS-MPs. Further, the cytotoxicity assay demonstrates that PMS displays good cytocompatibility. Altogether, this mode of administration has immense potential for the development of delivery of other drugs, as well as in the medical field.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Chemistry, Chemical Engineering and Life Sciences, Wuhan University of Technology, Wuhan 430070, P. R. China.
- School of Resources and Environmental Engineering, Wuhan University of Technology, Wuhan 430070, P. R. China.
- School of Materials Science and Engineering, Wuhan University of Technology, Wuhan 430070, P. R. China.
- Department of Plastic Surgery, Traditional Chinese and Western Medicine Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, P. R. China.
- Department of Plastic Surgery, Han kou Hospital, Wuhan 430012, P. R. China.
ORCID-Profile: Yingying Chu, Haixing Xu, Yue Zhang
Förderung
- Wuhan Science and Technology Project
- Sanya Yazhou Bay Science and Technology City
- Wuhan University of Technology
Zitieren
APA
Luo, W., Zhang, X., Chu, Y., Chen, T., Sun, H., Liu, J., Zhang, G., Fan, L., Xu, H., Zhang, Y., & Yang, M. (2024). Incorporation of Finasteride-Loaded Microspheres into Personalized Microneedle for Sustained Transdermal Delivery. Langmuir, 40(20), 10551-10560. https://doi.org/10.1021/acs.langmuir.4c00280
Vancouver
Luo W, Zhang X, Chu Y, Chen T, Sun H, Liu J, et al. Incorporation of Finasteride-Loaded Microspheres into Personalized Microneedle for Sustained Transdermal Delivery. Langmuir. 2024;40(20):10551-10560. doi:10.1021/acs.langmuir.4c00280
BibTeX
@article{Luo2024,
author = {Luo, Wenzuo and Zhang, Xingui and Chu, Yingying and Chen, Tiantian and Sun, Huixuan and Liu, Jiadong and Zhang, Guoxing and Fan, Lihong and Xu, Haixing and Zhang, Yue and Yang, Ming},
title = {Incorporation of Finasteride-Loaded Microspheres into Personalized Microneedle for Sustained Transdermal Delivery},
journal = {Langmuir},
year = {2024},
volume = {40},
number = {20},
pages = {10551--10560},
doi = {10.1021/acs.langmuir.4c00280}
}
EUVIMED